An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms

Authors: Theobald D.E.¹; Kirsh K.L.; Holtsclaw E.; Donaghy K.; Passik S.D.

Source: Journal of Pain and Symptom Management, Volume 23, Number 5, May 2002 , pp. 442-447(6)

Publisher: Elsevier

Keywords: Mirtazapine; advanced cancer; pain; depression; symptoms; quality of life

Language: English

Document Type: Short communication

DOI: 10.1016/S0885-3924(02)00381-0

Affiliations: 1: Oncology Symptom Control & Research, Community Cancer Care, , Indianapolis, IN, USA

Links for this article

http://www.ingentaconnect.com/els/08853924/2002/00000023/00000005/art00381
http://openurl.ingenta.com/content?genre=article&issn=0885-3924&volume=23&issue=5&spage=442&epage=447
http://dx.doi.org/10.1016/S0885-3924(02)00381-0